Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
AbbVie NYSE:ABBV |
370,38 B | 2,49% | 4/6 | 25,40% | -32,50% | 19,39% | DOWN |
|
Amgen NasdaqGS:AMGN |
188,01 B | 7,37% | 3/6 | 2,72% | -7,43% | 0,35% | UP |
|
Gilead Sciences NasdaqGS:GILD |
166,63 B | 3,30% | 5/6 | 4,53% | -52,59% | 19,18% | UP |
|
Alnylam Pharmaceuticals NasdaqGS:ALNY |
42,09 B | 46,06% | 4/6 | 49,91% | 4,20% | 41,79% | DOWN |
|
Alexion Pharmaceuticals NasdaqGM:ALXN |
40,34 B | 0,00% | 4/4 | 0,00% | 0,00% | -100,00% | UP |
|
Biogen NasdaqGS:BIIB |
26,98 B | -10,57% | 1/6 | -1,25% | 8,93% | 12,33% | UP |
|
Incyte NasdaqGS:INCY |
17,97 B | 41,79% | 5/6 | 8,73% | 31,17% | 17,94% | UP |
|
BioMarin Pharmaceutical NasdaqGS:BMRN |
10,41 B | 12,22% | 5/6 | 45,50% | 60,07% | 73,62% | DOWN |
|
Blueprint Medicines NasdaqGS:BPMC |
8,38 B | 45,26% | 4/6 | 42,18% | -48,48% | 0,64% | UP |
|
Arrowhead Pharmaceuticals NasdaqGS:ARWR |
8,09 B | 48,13% | 5/6 | -45,97% | 24,81% | 38,46% | UP |
|
Cidara Therapeutics NasdaqCM:CDTX |
6,97 B | -59,17% | 2/6 | 0,00% | -652349,57% | -100,00% | UP |
|
Arena Pharmaceuticals NasdaqGM:ARNA |
6,17 B | 0,00% | 0,00% | 0,00% | 0,00% | UP | |
|
Amicus Therapeutics NasdaqGM:FOLD |
4,53 B | 19,97% | 5/6 | 56,83% | -24,66% | 0,62% | UP |
|
Viking Therapeutics NasdaqCM:VKTX |
3,76 B | 0,00% | 0/4 | 0,00% | 0,00% | 205,97% | DOWN |
|
ChemoCentryx NasdaqGS:CCXI |
3,74 B | 0,00% | 0/4 | 0,00% | 0,00% | -100,00% | UP |
|
CymaBay Therapeutics NasdaqGS:CBAY |
3,72 B | 0,00% | 1/4 | 0,00% | 0,00% | -100,00% | UP |
|
ACADIA Pharmaceuticals NasdaqGS:ACAD |
3,54 B | 29,02% | 5/6 | 16,99% | 33,62% | 56,63% | DOWN |
|
Dicerna Pharmaceuticals NasdaqGM:DRNA |
2,99 B | 0,00% | 3/4 | 0,00% | 0,00% | -100,00% | UP |
|
Catalyst Pharmaceuticals NasdaqCM:CPRX |
2,86 B | 40,93% | 5/6 | 5,59% | 26,91% | 49,57% | UP |
|
Travere Therapeutics NasdaqGM:TVTX |
2,51 B | 10,07% | 5/6 | 42,67% | -38,25% | 54,13% | UP |
